Metraipolis › archive › dc_145260f2fdfd

Efficacy and Safety of Mirabegron 25 mg Versus Oral Desmopressin 120 mcg in Treatment of Primary Nocturnal Enuresis — Europe PMC PMID:42364198

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42364198
DOI: 10.5152/tud.2026.26009
License (as archived): solo-consultazione
Archived: 2026-11-02T09:03:40.716Z
SHA-256 of the archived text: 041831d5948859dcd5ca334c5c33dcf4d65584a2d0ffcfa300ccc84356597e23
Stable URL of this page: https://metraipolis.com/documento/dc_145260f2fdfd

How to cite

Efficacy and Safety of Mirabegron 25 mg Versus Oral Desmopressin 120 mcg in Treatment of Primary Nocturnal Enuresis — Europe PMC PMID:42364198 — Europe PMC (en), https://europepmc.org/article/MED/42364198 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_145260f2fdfd (Metraipolis archive dc_145260f2fdfd, sha256 041831d5948859dcd5ca334c5c33dcf4d65584a2d0ffcfa300ccc84356597e23)

BibTeX

@misc{dc145260f2fdfd,
  title = {Efficacy and Safety of Mirabegron 25 mg Versus Oral Desmopressin 120 mcg in Treatment of Primary Nocturnal Enuresis — Europe PMC PMID:42364198},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42364198},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_145260f2fdfd; sha256 041831d5948859dcd5ca334c5c33dcf4d65584a2d0ffcfa300ccc84356597e23},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42364198. Agents can read the archived copy with the MCP tool read_document.